Details for New Drug Application (NDA): 213105
✉ Email this page to a colleague
NDA 213105 describes CETIRIZINE HYDROCHLORIDE ALLERGY, which is a drug marketed by Apotex, Aurobindo Pharma Ltd, Bionpharma, Catalent, Onesource Specialty, Sun Pharm Inds Inc, Perrigo R And D, Aiping Pharm Inc, Amneal Pharms Ny, Apotex Inc, Cipla Ltd, Contract Pharmacal, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Granules, Heritage Pharma, Marksans Pharma, Mylan, Orbion Pharms, Pld Acquisitions, Sun Pharm Inds Ltd, Taro, Torrent Pharms Llc, Unichem, and Unique, and is included in twenty-eight NDAs. It is available from one hundred and thirty-two suppliers. Additional details are available on the CETIRIZINE HYDROCHLORIDE ALLERGY profile page.
The generic ingredient in CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-nine suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
The generic ingredient in CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-nine suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for 213105
| Tradename: | CETIRIZINE HYDROCHLORIDE ALLERGY |
| Applicant: | Catalent |
| Ingredient: | cetirizine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 213105
| Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 213105
Suppliers and Packaging for NDA: 213105
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 213105 | ANDA | L. Perrigo Company | 0113-0981 | 0113-0981-63 | 1 BOTTLE in 1 CARTON (0113-0981-63) / 25 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 213105 | ANDA | Safeway, Inc. | 21130-364 | 21130-364-25 | 1 BOTTLE, PLASTIC in 1 BOX (21130-364-25) / 25 CAPSULE in 1 BOTTLE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Sep 21, 2020 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
